NCT00106340View on ClinicalTrials.gov

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

3,118

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 20, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

glimepiride

DRUG

Metformin

DRUG

Vildagliptin matching placebo

DRUG

Glimepiride matching placebo

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers, Nuremberg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY